4 independently checked trend briefs about this subject, newest first.
headlinez.news detected 4 source-qualified news clusters connected to Pfizer between June 23, 2026 and June 30, 2026. They span 1 newsroom category and average 6.3 independent sources per brief.
This hub includes only briefs supported by at least four sources and passed by the site's verification gate. Raw or weak detections may exist but are excluded here. Topic matching is based on the entities and themes recorded with each brief; open a card to inspect its source links, publication time, verification label and velocity history. Read the methodology and editorial policy for the full rules.
A US House committee has launched an investigation into pharmaceutical companies regarding clinical trial sites located in China.
Nike taps Pfizer finance veteran to steer financial turnaround amid leadership shift
Pfizer’s experimental lung cancer drug sigvotatug vedotin has failed to meet its primary objective in a late-stage clinical trial.
Pfizer’s first drug candidate from its Seagen acquisition, sigvotatug vedotin, failed to meet primary endpoints in a Phase 3 nonsquamous NSCLC trial.